Complete response to third-line treatment with trifluridine/tipiracil (TAS-102) in stage IV colon adenocarcinoma by Celia Lara-Morga, Magda Palka-Kotlowska, Sara Custodio-Cabello, Vilma Pacheco-Barcia, Luis Cabezón-Gutiérrez

Get full text

The Homologous Recombination Deficiency Scar in Advanced Cancer: Agnostic Targeting of Damaged DNA Repair by Vilma Pacheco-Barcia, Andrés Muñoz, Elena Castro, Ana Isabel Ballesteros, Gloria Marquina, Iván González-Díaz, Ramon Colomer, Nuria Romero-Laorden

Get full text

Stoic attitude in patients with cancer from the NEOcoping study: Cross-sectional study. by David Gomez, Alberto Carmona-Bayonas, Raquel Hernandez, Oliver Higuera, Jacobo Rogado, Vilma Pacheco-Barcia, María Valero, Mireia Gil-Raga, M Mar Muñoz, Rafael Carrión-Galindo, Paula Jimenez-Fonseca, Caterina Calderon

Get full text

Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLC by Jacobo Rogado, Fernando Pozo, Kevin Troule, José Miguel Sánchez-Torres, Nuria Romero-Laorden, Rebeca Mondejar, Olga Donnay, Anabel Ballesteros, Vilma Pacheco-Barcia, Javier Aspa, Fátima Al-Shahrour, Arantzazu Alfranca, Ramon Colomer

Get full text

Psychological distress and resilience in patients with advanced cancer during the Covid-19 pandemic: the mediating role of spirituality by Luka Mihic-Gongora, Paula Jiménez-Fonseca, Raquel Hernandez, Mireia Gil-Raga, Vilma Pacheco-Barcia, Aránzazu Manzano-Fernández, Susana Hernando-Polo, Mónica Antoñanzas-Basa, María J. Corral, María Valero-Arbizu, Caterina Calderon

Get full text

Prediction of quality of life in early breast cancer upon completion of adjuvant chemotherapy by Alberto Carmona-Bayonas, Caterina Calderón, Raquel Hernández, Ana Fernández Montes, Beatriz Castelo, Laura Ciria-Suarez, Mónica Antoñanzas, Jacobo Rogado, Vilma Pacheco-Barcia, Elena Asensio Martínez, Alejandra Ivars, Francisco Ayala de la Peña, Paula Jimenez-Fonseca

Get full text

Effect of excess weight and immune-related adverse events on the efficacy of cancer immunotherapy with anti-PD-1 antibodies by Jacobo Rogado, Nuria Romero-Laorden, José Miguel Sanchez-Torres, Ana María Ramos-Levi, Vilma Pacheco-Barcia, Ana Isabel Ballesteros, Reyes Arranz, Alicia Lorenzo, Pedro Gullon, Ana Garrido, José María Serra López-Matencio, Olga Donnay, Magdalena Adrados, Pablo Costas, Javier Aspa, Arantzazu Alfranca, Rebeca Mondejar, Ramon Colomer

Get full text

The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy by Paula Jimenez-Fonseca, Victoria Foy, Sophie Raby, Alberto Carmona-Bayonas, Lola Macía-Rivas, Virginia Arrazubi, Diego Cacho Lavin, Raquel Hernandez San Gil, Ana Custodio, Juana María Cano, Ana Fernández Montes, Oriol Mirallas, Ismael Macias Declara, Rosario Vidal Tocino, Laura Visa, María Luisa Limón, Paola Pimentel, Nieves Martínez Lago, Tamara Sauri, Marta Martín Richard, Monserrat Mangas, Mireia Gil Raga, Aitana Calvo, Pablo Reguera, Mónica Granja, Alfonso Martín Carnicero, Carolina Hernández Pérez, Paula Cerdá, Lucía Gomez Gonzalez, Francisco Garcia Navalon, Vilma Pacheco Barcia, David Gutierrez Abad, Maribel Ruiz Martín, Jamie Weaver, Wasat Mansoor, Javier Gallego

Get full text